AMPH - Amphastar Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$23.00
DETAILS
HIGH:
$30.00
LOW:
$19.00
MEDIAN:
$21.50
CONSENSUS:
$23.00
UPSIDE:
24.93%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 719.9 | 732.0 | 644.4 | 499.0 | 437.8 | 349.8 | 322.4 | 294.7 | 240.2 | 255.2 | 251.5 | 210.5 | 229.7 | 204.3 | 118.4 |
| Cost of Revenue | 363.8 | 358.1 | 293.3 | 250.1 | 238.0 | 206.5 | 190.4 | 187.7 | 149.4 | 151.0 | 174.2 | 159.2 | 142.7 | 114.0 | 90.3 |
| Gross Profit | 356.1 | 373.9 | 351.1 | 248.9 | 199.7 | 143.3 | 131.9 | 107.0 | 90.8 | 104.2 | 77.3 | 51.3 | 87.0 | 90.3 | 28.1 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 85.8 | 73.9 | 73.7 | 74.8 | 60.9 | 67.2 | 68.9 | 57.6 | 43.4 | 41.2 | 37.1 | 28.4 | 33.0 | 31.2 | 31.0 |
| SG&A Expenses | 129.8 | 94.5 | 80.4 | 66.6 | 68.9 | 65.2 | 63.1 | 58.0 | 50.9 | 47.3 | 47.0 | 40.4 | 36.3 | 31.6 | 30.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.7) | 0 | (0.2) | 0.5 | 0 | 0 |
| Operating Expenses | 215.7 | 168.4 | 154.1 | 141.4 | 129.9 | 132.4 | 132.0 | 115.6 | 94.3 | 88.5 | 84.0 | 68.8 | 69.3 | 62.8 | 61.6 |
| Operating Income | |||||||||||||||
| Operating Income | 140.4 | 205.4 | 197.0 | 107.5 | 69.9 | 11.0 | (0.0) | (8.6) | (0.9) | 15.7 | (6.9) | (18.0) | 17.5 | 25.4 | (33.5) |
| Interest Expense | 25.5 | 30.3 | 27.2 | 1.8 | 0.9 | 0.4 | 0.1 | 0.2 | 0.8 | 1.0 | 1.0 | 0.6 | 1.0 | 0.8 | 0.6 |
| Interest Income | 8.7 | 10.6 | 5.5 | 1.3 | 0.6 | 0.6 | 1.0 | 0.5 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | 0.2 | 0.4 |
| Profitability | |||||||||||||||
| EBITDA | 149.1 | 277.3 | 240.3 | 146.2 | 111.6 | 30.2 | 81.5 | 6.8 | 11.9 | 30.5 | 3.9 | (3.1) | 30.7 | 38.2 | (20.2) |
| EBIT | 149.1 | 220.1 | 198.5 | 117.9 | 85.0 | 5.0 | 60.3 | (9.7) | 2.1 | 16.0 | (9.4) | (17.5) | 17.6 | 26.7 | (31.3) |
| Income Before Tax | 123.6 | 189.2 | 169.4 | 114.9 | 83.9 | 4.6 | 60.2 | (9.9) | 1.6 | 14.9 | (10.4) | (18.1) | 17.2 | 25.9 | (31.9) |
| Income Tax Expense | 25.5 | 29.7 | 31.8 | 23.5 | 20.6 | 3.5 | 13.7 | (3.3) | (2.9) | 4.4 | (7.6) | (7.4) | 5.4 | 7.8 | (39.6) |
| Net Income | 98.1 | 159.5 | 137.5 | 91.4 | 62.1 | 1.4 | 48.9 | (5.7) | 4.5 | 10.5 | (2.8) | (10.7) | 11.9 | 18.1 | 7.8 |
| Per Share Data | |||||||||||||||
| EPS (Basic) | 2.10 | 3.29 | 2.85 | 1.88 | 1.30 | 0.03 | 1.04 | -0.12 | 0.10 | 0.23 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| EPS (Diluted) | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 | 0.03 | 0.98 | -0.12 | 0.09 | 0.22 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| Shares Outstanding | 46.7 | 48.4 | 48.3 | 48.6 | 47.8 | 47.0 | 47.0 | 46.4 | 46.1 | 45.4 | 45.0 | 42.0 | 8 | 8 | 8 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 170.2 | 151.6 | 144.3 | 156.1 | 126.4 | 92.6 | 75.5 | 86.3 | 65.6 | 72.4 |
| Short-Term Investments | 112.6 | 70.0 | 112.5 | 19.7 | 10.3 | 13.0 | 14.0 | 2.8 | 2.6 | 0.5 |
| Net Receivables | 143.6 | 138.0 | 115.5 | 88.8 | 78.8 | 66.0 | 45.4 | 52.2 | 36.0 | 26.8 |
| Inventory | 176.9 | 153.7 | 105.8 | 103.6 | 92.8 | 96.8 | 110.5 | 69.3 | 63.6 | 79.8 |
| Other Current Assets | 32.8 | 20.6 | 11.5 | 2.6 | 2.6 | 4.5 | 9.8 | 4.2 | 10.2 | 1.4 |
| Total Current Assets | 636.0 | 534.1 | 489.6 | 378.3 | 318.1 | 279.7 | 255.2 | 220.3 | 187.8 | 184.1 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 353.7 | 344.6 | 315.6 | 264.6 | 271.5 | 280.7 | 253.5 | 210.4 | 185.3 | 152.9 |
| Goodwill | 3.4 | 3.0 | 3.2 | 3.1 | 3.3 | 3.9 | 3.6 | 4.0 | 4.5 | 4.0 |
| Intangible Assets | 562.6 | 587.6 | 610.1 | 34.2 | 35.6 | 36.7 | 37.5 | 38.3 | 40.7 | 46.3 |
| Long-Term Investments | 0 | 11.0 | 15.2 | 2.4 | 4.0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 31.1 | 26.0 | 25.9 | 20.9 | 16.7 | 5.2 | 11.2 | 9.9 | 8.7 | 9.4 |
| Total Non-Current Assets | 993.3 | 1,043.4 | 1,023.3 | 363.7 | 353.4 | 351.6 | 331.7 | 293.2 | 266.9 | 243.6 |
| Total Assets | 1,629.3 | 1,577.5 | 1,512.9 | 742.0 | 671.5 | 631.2 | 587.0 | 513.6 | 454.7 | 427.7 |
| Current Liabilities | ||||||||||
| Account Payables | 32.6 | 30.5 | 25.4 | 20.5 | 22.2 | 24.4 | 25.1 | 31.3 | 16.6 | 19.9 |
| Short-Term Debt | 1.6 | 0.2 | 0.4 | 3.0 | 2.2 | 12.3 | 10.9 | 18.2 | 6.3 | 5.4 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (56.1) | 0 | 0.1 |
| Other Current Liabilities | 0 | 0 | 0 | 17.6 | 23.2 | 25.2 | 30.1 | 0 | 7.8 | 7.7 |
| Total Current Liabilities | 158.2 | 173.8 | 225.4 | 94.9 | 103.8 | 112.2 | 90.0 | 106.8 | 67.2 | 60.6 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 608.7 | 601.6 | 589.6 | 72.8 | 74.4 | 33.9 | 38.9 | 32.0 | 40.8 | 32.4 |
| Deferred Tax Liabilities | 5.9 | 7.0 | 6.1 | 7.4 | 7.1 | 5.5 | 0.9 | 1.4 | 2.2 | 2.3 |
| Other Non-Current Liabilities | 30.0 | 20.9 | 22.7 | 14.6 | 15.7 | 13.2 | 12.9 | 9.4 | 7.9 | 4.0 |
| Total Non-Current Liabilities | 682.3 | 671.4 | 648.1 | 118.5 | 122.2 | 70.3 | 69.4 | 42.4 | 50.1 | 37.9 |
| Total Liabilities | 840.5 | 845.2 | 873.5 | 213.3 | 226.0 | 182.5 | 159.4 | 149.2 | 117.3 | 98.5 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | 666.9 | 568.8 | 409.3 | 271.7 | 180.3 | 117.8 | 116.4 | 67.5 | 76.2 | 70.9 |
| Accumulated Other Comprehensive Income | (5.3) | (9.2) | (8.5) | (8.6) | (6.8) | (3.7) | (4.7) | (4.0) | (2.1) | (4.7) |
| Total Stockholders' Equity | 788.8 | 732.3 | 639.4 | 528.7 | 445.5 | 402.3 | 381.4 | 332.4 | 337.3 | 329.3 |
| Total Liabilities & Equity | 1,629.3 | 1,577.5 | 1,512.9 | 742.0 | 671.5 | 631.2 | 587.0 | 513.6 | 454.7 | 427.7 |
| Debt Metrics | ||||||||||
| Total Debt | 656.0 | 650.5 | 623.6 | 102.6 | 104.7 | 67.3 | 66.6 | 50.2 | 47.2 | 37.7 |
| Net Debt | 485.8 | 498.9 | 479.3 | (53.5) | (21.7) | (25.4) | (8.9) | (36.1) | (18.4) | (34.6) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 98.1 | 159.5 | 137.5 | 91.4 | 63.3 | 1.1 | 46.5 | (6.7) | 4.5 | 10.5 |
| Depreciation & Amortization | 63.2 | 57.2 | 41.8 | 28.7 | 26.8 | 25.2 | 21.1 | 16.5 | 15.4 | 14.6 |
| Stock-Based Compensation | 27.3 | 24.4 | 20.2 | 17.9 | 18.7 | 20.5 | 17.3 | 16.7 | 17.1 | 15.1 |
| Change in Working Capital | (66.0) | (14.5) | (24.2) | (32.2) | (1.9) | 9.1 | (51.7) | 12.1 | 0.6 | 0.3 |
| Other Non-Cash Items | 5.9 | 4.7 | 21.9 | (0.9) | (13.0) | 0.2 | 1.0 | 1.4 | (2.3) | 1.3 |
| Operating Cash Flow | 156.1 | 213.4 | 183.5 | 89.2 | 98.0 | 57.3 | 41.8 | 38.2 | 39.2 | 38.6 |
| Investing Activities | ||||||||||
| Capital Expenditure | (34.9) | (41.0) | (38.2) | (24.0) | (27.5) | (33.9) | (41.6) | (46.8) | (35.1) | (21.4) |
| Acquisitions | 0 | (129) | (506.4) | 0.4 | 0 | 0 | 0 | 4.6 | 2 | (12.5) |
| Purchases of Investments | (119.1) | (76.8) | (144.6) | (35.8) | (17.4) | (13.6) | (8.8) | (0.3) | (5.6) | (3.6) |
| Sales/Maturities of Investments | 90.3 | 126.0 | 38.6 | 28.0 | 18.8 | 12.4 | 0 | 0.1 | 3.6 | 3.1 |
| Other Investing Activities | (6.6) | (4.1) | 1.4 | (1.4) | (2.6) | (1.4) | (0.2) | 0.2 | (3.7) | (5.1) |
| Investing Cash Flow | (70.3) | (124.9) | (649.1) | (32.8) | (28.7) | (36.4) | (50.5) | (42.2) | (38.8) | (39.5) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 5.3 | 10.2 | 526.3 | (1.8) | 32.1 | (0.9) | (3.2) | 3.1 | 9.3 | (4.5) |
| Stock Repurchased | (75.6) | (85.5) | (58.1) | (39.9) | (28.9) | (24.4) | (22.3) | (25.0) | (30.7) | (9.9) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (5.7) | (14.1) | 15.3 | (40.2) | 23.1 | 3.4 | 8.9 | 13.8 | 21.5 |
| Financing Cash Flow | (67.4) | (81.0) | 454.1 | (26.4) | (37.0) | (2.2) | (3.8) | 25.0 | (7.7) | 7.1 |
| Cash Position | ||||||||||
| Net Change in Cash | 18.6 | 7.3 | (11.8) | 29.7 | 32.1 | 19.0 | (12.7) | 20.7 | (6.8) | 6.3 |
| Cash at Beginning | 151.8 | 144.5 | 156.3 | 126.6 | 94.5 | 75.5 | 88.2 | 67.5 | 72.4 | 66.1 |
| Cash at End | 170.4 | 151.8 | 144.5 | 156.3 | 126.6 | 94.5 | 75.5 | 88.2 | 65.6 | 72.4 |
| Free Cash Flow | 121.2 | 172.3 | 145.3 | 65.1 | 70.5 | 23.4 | 0.2 | (8.6) | 4.1 | 17.2 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 719.9 | 732.0 | 644.4 | 499.0 | 437.8 | 349.8 | 322.4 | 294.7 | 240.2 | 255.2 | 251.5 | 210.5 | 229.7 | 204.3 | 118.4 |
| Gross Profit | 356.1 | 373.9 | 351.1 | 248.9 | 199.7 | 143.3 | 131.9 | 107.0 | 90.8 | 104.2 | 77.3 | 51.3 | 87.0 | 90.3 | 28.1 |
| Operating Income | 140.4 | 205.4 | 197.0 | 107.5 | 69.9 | 11.0 | (0.0) | (8.6) | (0.9) | 15.7 | (6.9) | (18.0) | 17.5 | 25.4 | (33.5) |
| Net Income | 98.1 | 159.5 | 137.5 | 91.4 | 62.1 | 1.4 | 48.9 | (5.7) | 4.5 | 10.5 | (2.8) | (10.7) | 11.9 | 18.1 | 7.8 |
| EPS (Diluted) | 2.03 | 3.06 | 2.60 | 1.74 | 1.25 | 0.03 | 0.98 | -0.12 | 0.09 | 0.22 | -0.06 | -0.25 | 1.48 | 2.26 | 0.97 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 170.2 | 151.6 | 144.3 | 156.1 | 126.4 | 92.6 | 75.5 | 86.3 | 65.6 | 72.4 | |||||
| Total Assets | 1,629.3 | 1,577.5 | 1,512.9 | 742.0 | 671.5 | 631.2 | 587.0 | 513.6 | 454.7 | 427.7 | |||||
| Total Debt | 656.0 | 650.5 | 623.6 | 102.6 | 104.7 | 67.3 | 66.6 | 50.2 | 47.2 | 37.7 | |||||
| Stockholders' Equity | 788.8 | 732.3 | 639.4 | 528.7 | 445.5 | 402.3 | 381.4 | 332.4 | 337.3 | 329.3 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | 156.1 | 213.4 | 183.5 | 89.2 | 98.0 | 57.3 | 41.8 | 38.2 | 39.2 | 38.6 | |||||
| Capital Expenditure | (34.9) | (41.0) | (38.2) | (24.0) | (27.5) | (33.9) | (41.6) | (46.8) | (35.1) | (21.4) | |||||
| Free Cash Flow | 121.2 | 172.3 | 145.3 | 65.1 | 70.5 | 23.4 | 0.2 | (8.6) | 4.1 | 17.2 | |||||